The Role of Ect2 Nuclear RhoGEF Activity in Ovarian Cancer Cell Transformation

Genes and Cancer

Volumn 4, Issue 11-12, 2013, Pages 460-475

  Huff, Lauren P ^a   DeCristo, Molly J ^a   Trembath, Dimitri ^a   Kuan, Pei Fen ^b   Yim, Margaret ^c   Liu, Jinsong ^d   Cook, Danielle R ^e   Miller, C Ryan ^a,e   Der, Channing J ^a,e   Cox, Adrienne D ^a,e  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c YALE UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Ect2; ovarian cancer; Rac; RhoGEF

Indexed keywords

EPITHELIAL CELL TRANSFORMING SEQUENCE 2; GUANOSINE TRIPHOSPHATASE; MESSENGER RNA; RAC PROTEIN; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL FRACTIONATION; CELL GROWTH; CELL SIGNALING ASSAY; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MICROSCOPY; MOLECULAR GENETICS; OVARY CANCER; PRIORITY JOURNAL; TISSUE MICROARRAY;

EID: 84891531737     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601913514851     Document Type: Article

References (82)

1. Hall A.Rho family GTPases.Biochem Soc Trans. 2012;40 (6): 1378-82.
2. Vega FM,Ridley AJ.SnapShot: Rho family GTPases.Cell. 2007 1430;129 (7):.
3. Sahai E,Marshall CJ.RHO-GTPases and cancer.Nat Rev Cancer. 2002;2 (2): 133-42.
4. Vega FM,Ridley AJ.Rho GTPases in cancer cell biology.FEBS Lett. 2008;582 (14): 2093-101.
5. Ellenbroek SI,Collard JG.Rho GTPases: functions and association with cancer.Clin Exp Metastasis. 2007;24 (8): 657-72.
6. Rossman KL,Der CJ,Sondek J.GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors.Nat Rev Mol Cell Biol. 2005;6 (2): 167-80.
7. Tatsumoto T,Xie X,Blumenthal R,Okamoto I,Miki T.Human ECT2 is an exchange factor for Rho GTPases, phosphorylated in G2/M phases, and involved in cytokinesis.J Cell Biol. 1999;147 (5): 921-8.
8. Saito S,Liu XF,Kamijo K, et al.Deregulation and mislocalization of the cytokinesis regulator ECT2 activate the Rho signaling pathways leading to malignant transformation.J Biol Chem. 2004;279 (8): 7169-79.
9. Liu XF,Ishida H,Raziuddin R,Miki T.Nucleotide exchange factor ECT2 interacts with the polarity protein complex Par6/Par3/protein kinase Czeta (PKCzeta) and regulates PKCzeta activity.Mol Cell Biol. 2004;24 (15): 6665-75.
10. Kimura K,Tsuji T,Takada Y,Miki T,Narumiya S.Accumulation of GTP-bound RhoA during cytokinesis and a critical role of ECT2 in this accumulation.J Biol Chem. 2000;275 (23): 17233-6.
11. Kanada M,Nagasaki A,Uyeda TQ.Novel functions of Ect2 in polar lamellipodia formation and polarity maintenance during "contractile ring-independent" cytokinesis in adherent cells.Mol Biol Cell. 2008;19 (1): 8-16.
12. Fields AP,Justilien V.The guanine nucleotide exchange factor (GEF) Ect2 is an oncogene in human cancer.Adv Enzyme Regul. 2009;50 (1): 190-200.
13. Weeks A,Okolowsky N,Golbourn B,Ivanchuk S,Smith C,Rutka JT.ECT2 and RASAL2 mediate mesenchymal-amoeboid transition in human astrocytoma cells.Am J Pathol. 2012;181 (2): 662-74.
14. Fortin SP,Ennis MJ,Schumacher CA, et al.Cdc42 and the guanine nucleotide exchange factors Ect2 and trio mediate Fn14-induced migration and invasion of glioblastoma cells.Mol Cancer Res. 2012;10 (7): 958-68.
15. Justilien V,Fields AP.Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation.Oncogene. 2009;28 (41): 3597-607.
16. Wang H,Linghu H,Wang J, et al.The role of Crk/Dock180/Rac1 pathway in the malignant behavior of human ovarian cancer cell SKOV3.Tumour Biol. 2010;31 (1): 59-67.
17. Bourguignon LY,Gilad E,Rothman K,Peyrollier K.Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression.J Biol Chem. 2005;280 (12): 11961-72.
18. Zhao Y,Zong ZH,Xu HM.RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9.Gynecol Oncol. 2009;116 (3): 563-71.
19. Horiuchi A,Kikuchi N,Osada R, et al.Overexpression of RhoA enhances peritoneal dissemination: RhoA suppression with Lovastatin may be useful for ovarian cancer.Cancer Sci. 2008;99 (12): 2532-9.
20. Takai S,Long JE,Yamada K,Miki T.Chromosomal localization of the human ECT2 proto-oncogene to 3q26.1→q26.2 by somatic cell analysis and fluorescence in situ hybridization.Genomics. 1995;27 (1): 220-2.
21. Suzuki S,Moore DH,Ginzinger DG, et al.An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer.Cancer Res. 2000;60 (19): 5382-5.
22. Haverty PM,Hon LS,Kaminker JS,Chant J,Zhang Z.High-resolution analysis of copy number alterations and associated expression changes in ovarian tumors.BMC Med Genomics. 2009;2:21.
23. Cerami E,Gao J,Dogrusoz U, et al.The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.Cancer Discov. 2012;2 (5): 401-4.
24. Nature. 2011;474 (7353): 609-15.
25. Saito S,Tatsumoto T,Lorenzi MV, et al.Rho exchange factor ECT2 is induced by growth factors and regulates cytokinesis through the N-terminal cell cycle regulator-related domains.J Cell Biochem. 2003;90 (4): 819-36.
26. Rosen DG,Cai KQ,Luthra R,Liu J.Immunohistochemical staining of hMLH1 and hMSH2 reflects microsatellite instability status in ovarian carcinoma.Mod Pathol. 2006;19 (11): 1414-20.
27. Rosen DG,Mercado-Uribe I,Yang G, et al.The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.Cancer. 2006;107 (11): 2730-40.
28. Rosen DG,Yang G,Deavers MT, et al.Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma.Cancer. 2006;106 (9): 1925-32.
29. Stevens EV,Banet N,Onesto C, et al.RhoGDI2 antagonizes ovarian carcinoma growth, invasion and metastasis.Small GTPases. 2011;2 (4): 202-10.
30. Freedman VH,Shin SI.Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium.Cell. 1974;3 (4): 355-9.
31. Li J,Wang J,Jiao H,Liao J,Xu X.Cytokinesis and cancer: polo loves ROCK'n' Rho(A).J Genet Genomics. 2010;37 (3): 159-72.
32. Williams CL.The polybasic region of Ras and Rho family small GTPases: a regulator of protein interactions and membrane association and a site of nuclear localization signal sequences.Cell Signal. 2003;15 (12): 1071-80.
33. Lanning CC,Ruiz-Velasco R,Williams CL.Novel mechanism of the co-regulation of nuclear transport of SmgGDS and Rac1.J Biol Chem. 2003;278 (14): 12495-506.
34. Michaelson D,Abidi W,Guardavaccaro D, et al.Rac1 accumulates in the nucleus during the G2 phase of the cell cycle and promotes cell division.J Cell Biol. 2008;181 (3): 485-96.
35. Borikova AL,Dibble CF,Sciaky N, et al.Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype.J Biol Chem. 2010;285 (16): 11760-4.
36. Dubash AD,Guilluy C,Srougi MC,Boulter E,Burridge K,Garcia-Mata R.The small GTPase RhoA localizes to the nucleus and is activated by Net1 and DNA damage signals.PLoS One. 2011;6 (2): e17380.
37. Hara T,Abe M,Inoue H, et al.Cytokinesis regulator ECT2 changes its conformation through phosphorylation at Thr-341 in G2/M phase.Oncogene. 2006;25 (4): 566-78.
38. Guilluy C,Dubash AD,Garcia-Mata R.Analysis of RhoA and Rho GEF activity in whole cells and the cell nucleus.Nat Protoc. 2011;6 (12): 2050-60.
39. Garcia-Mata R,Wennerberg K,Arthur WT,Noren NK,Ellerbroek SM,Burridge K.Analysis of activated GAPs and GEFs in cell lysates.Methods Enzymol. 2006;406:425-37.
40. Arthur WT,Ellerbroek SM,Der CJ,Burridge K,Wennerberg K.XPLN, a guanine nucleotide exchange factor for RhoA and RhoB, but not RhoC.J Biol Chem. 2002;277 (45): 42964-72.
41. Ellerbroek SM,Wennerberg K,Arthur WT, et al.SGEF, a RhoG guanine nucleotide exchange factor that stimulates macropinocytosis.Mol Biol Cell. 2004;15 (7): 3309-19.
42. Chiu VK,Bivona T,Hach A, et al.Ras signalling on the endoplasmic reticulum and the Golgi.Nat Cell Biol. 2002;4 (5): 343-50.
43. Bivona TG,Quatela S,Philips MR.Analysis of Ras activation in living cells with GFP-RBD.Methods Enzymol. 2006;407:128-43.
44. Bivona TG,Perez De Castro I,Ahearn IM, et al.Phospholipase Cgamma activates Ras on the Golgi apparatus by means of RasGRP1.Nature. 2003;424 (6949): 694-8.
45. Alan JK,Berzat AC,Dewar BJ,Graves LM,Cox AD.Regulation of the Rho family small GTPase Wrch-1/RhoU by C-terminal tyrosine phosphorylation requires Src.Mol Cell Biol. 2010;30 (17): 4324-38.
46. Chenette EJ,Mitin NY,Der CJ.Multiple sequence elements facilitate Chp Rho GTPase subcellular location, membrane association, and transforming activity.Mol Biol Cell. 2006;17 (7): 3108-21.
47. Tapon N,Nagata K,Lamarche N,Hall A.A new rac target POSH is an SH3-containing scaffold protein involved in the JNK and NF-kappaB signalling pathways.EMBO J. 1998;17 (5): 1395-404.
48. Molli PR,Li DQ,Murray BW,Rayala SK,Kumar R.PAK signaling in oncogenesis.Oncogene. 2009;28 (28): 2545-55.
49. Blumenstein L,Ahmadian MR.Models of the cooperative mechanism for Rho effector recognition: implications for RhoA-mediated effector activation.J Biol Chem. 2004;279 (51): 53419-26.
50. Ridley AJ,Hall A.The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors.Cell. 1992;70 (3): 389-99.
51. Ridley AJ,Paterson HF,Johnston CL,Diekmann D,Hall A.The small GTP-binding protein rac regulates growth factor-induced membrane ruffling.Cell. 1992;70 (3): 401-10.
52. Lin R,Bagrodia S,Cerione R,Manor D.A novel Cdc42Hs mutant induces cellular transformation.Curr Biol. 1997;7 (10): 794-7.
53. Joyce PL,Cox AD.Rac1 and Rac3 are targets for geranylgeranyltransferase I inhibitor-mediated inhibition of signaling, transformation, and membrane ruffling.Cancer Res. 2003;63 (22): 7959-67.
54. Kalderon D,Roberts BL,Richardson WD,Smith AE.A short amino acid sequence able to specify nuclear location.Cell. 1984;39 (3 Pt 2): 499-509.
55. Ratheesh A,Gomez GA,Priya R, et al.Centralspindlin and alpha-catenin regulate Rho signalling at the epithelial zonula adherens.Nat Cell Biol. 2012;14 (8): 818-28.
56. Iyoda M,Kasamatsu A,Ishigami T, et al.Epithelial cell transforming sequence 2 in human oral cancer.PLoS One. 2010;5 (11): e14082.
57. Cook DR,Solski PA,Bultman SJ, et al.The ect2 rho Guanine nucleotide exchange factor is essential for early mouse development and normal cell cytokinesis and migration.Genes Cancer. 2011;2 (10): 932-42.
58. Justilien V,Jameison L,Der CJ,Rossman KL,Fields AP.The oncogenic activity of ECT2 is regulated through protein kinase C{iota} mediated phosphorylation.J Biol Chem. 2011;286 (10): 8149-57.
59. Hirata D,Yamabuki T,Miki D, et al.Involvement of epithelial cell transforming sequence-2 oncoantigen in lung and esophageal cancer progression.Clin Cancer Res. 2009;15 (1): 256-66.
60. Salhia B,Tran NL,Chan A, et al.The guanine nucleotide exchange factors trio, Ect2, and Vav3 mediate the invasive behavior of glioblastoma.Am J Pathol. 2008;173 (6): 1828-38.
61. Kim JE,Billadeau DD,Chen J.The tandem BRCT domains of Ect2 are required for both negative and positive regulation of Ect2 in cytokinesis.J Biol Chem. 2005;280 (7): 5733-9.
62. Lagana A,Dorn JF,De Rop V,Ladouceur AM,Maddox AS,Maddox PS.A small GTPase molecular switch regulates epigenetic centromere maintenance by stabilizing newly incorporated CENP-A.Nat Cell Biol. 2010;12 (12): 1186-93.
63. Niiya F,Tatsumoto T,Lee KS,Miki T.Phosphorylation of the cytokinesis regulator ECT2 at G2/M phase stimulates association of the mitotic kinase Plk1 and accumulation of GTP-bound RhoA.Oncogene. 2006;25 (6): 827-37.
64. Solski PA,Wilder RS,Rossman KL, et al.Requirement for C-terminal sequences in regulation of Ect2 guanine nucleotide exchange specificity and transformation.J Biol Chem. 2004;279 (24): 25226-33.
65. Oceguera-Yanez F,Kimura K,Yasuda S, et al.Ect2 and MgcRacGAP regulate the activation and function of Cdc42 in mitosis.J Cell Biol. 2005;168 (2): 221-32.
66. Kawashima T,Bao YC,Minoshima Y, et al.A Rac GTPase-activating protein, MgcRacGAP, is a nuclear localizing signal-containing nuclear chaperone in the activation of STAT transcription factors.Mol Cell Biol. 2009;29 (7): 1796-813.
67. Wang SM,Ooi LL,Hui KM.Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma.Clin Cancer Res. 2011;17 (18): 6040-51.
68. Tao J,Oladimeji P,Rider L,Diakonova M.PAK1-Nck regulates cyclin D1 promoter activity in response to prolactin.Mol Endocrinol. 2011;25 (9): 1565-78.
69. Obrdlik A,Percipalle P.The F-actin severing protein cofilin-1 is required for RNA polymerase II transcription elongation.Nucleus. 2011;2 (1): 72-9.
70. Kasai M,Guerrero-Santoro J,Friedman R,Leman ES,Getzenberg RH,DeFranco DB.The Group 3 LIM domain protein paxillin potentiates androgen receptor transactivation in prostate cancer cell lines.Cancer Res. 2003;63 (16): 4927-35.
71. Siu MK,Chan HY,Kong DS, et al.p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients.Proc Natl Acad Sci U S A. 2010;107 (43): 18622-7.
72. Siu MK,Wong ES,Chan HY, et al.Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion.Int J Cancer. 2010;127 (1): 21-31.
73. Mao YS,Zhang B,Spector DL.Biogenesis and function of nuclear bodies.Trends Genet. 2011;27 (8): 295-306.
74. Woods NT,Mesquita RD,Sweet M, et al.Charting the landscape of tandem BRCT domain-mediated protein interactions.Sci Signal. 2012;5 (242): rs6.
75. Srougi MC,Burridge K.The nuclear guanine nucleotide exchange factors Ect2 and Net1 regulate RhoB-mediated cell death after DNA damage.PLoS One. 2011;6 (2): e17108.
76. Grabocka E,Wedegaertner PB.Disruption of oligomerization induces nucleocytoplasmic shuttling of leukemia-associated rho Guanine-nucleotide exchange factor.Mol Pharmacol. 2007;72 (4): 993-1002.
77. Rao S,Lyons LS,Fahrenholtz CD, et al.A novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancer.Oncogene. 2012;31 (6): 716-27.
78. Fiordalisi JJ,Keller PJ,Cox AD.PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.Cancer Res. 2006;66 (6): 3153-61.
79. Benink HA,Bement WM.Concentric zones of active RhoA and Cdc42 around single cell wounds.J Cell Biol. 2005;168 (3): 429-39.
80. Abdi KM,Bennett V.Adducin promotes micrometer-scale organization of beta2-spectrin in lateral membranes of bronchial epithelial cells.Mol Biol Cell. 2008;19 (2): 536-45.
81. Brady DC,Alan JK,Madigan JP,Fanning AS,Cox AD.The transforming Rho family GTPase Wrch-1 disrupts epithelial cell tight junctions and epithelial morphogenesis.Mol Cell Biol. 2009;29 (4): 1035-49.
82. Hanker AB,Morita S,Repasky GA,Ross DT,Seitz RS,Der CJ.Tools to study the function of the Ras-related, estrogen-regulated growth inhibitor in breast cancer.Methods Enzymol. 2008;439:53-72.